Pharma/Biotech - Page 1 | TalkMarkets
All Posts > Content under Pharma/Biotech
1 to 16 of 1963 Posts
1 2 3 ... 123
Biotech Breakout: Healthcare Stocks Lead The Way
Article By: Rod Raynovich
Thursday, June 22, 2017 2:40 PM EDT
The BIO 2017 International Convention in San Diego got a big boost with investors piling into biotechnology and healthcare stocks. 2017 Biotech Run Has Been Impressive but what can we buy now?
In this article: XBI, XLV, IBB, AGIO, BLUE, BMY, CELG, CLVS, EPZM, EXEL, INCY, KITE, LOXO, MRK, NVS, PBYI, RHHBY, SGEN, TSRO
Read
Corbus Moves Lead Candidate To Phase 3 Study, Offers Good Investment Deal
Article By: KKD Healthcare Analytics
Thursday, June 22, 2017 9:33 AM EDT
Corbus has several catalysts coming up as it progresses with the testing of its lead drug candidate for different indications. Its earliest upcoming catalyst is in the fourth quarter.
In this article: CRBP
Read
Is The Market A False Hologram We’re Trained To See?
Article By: Michele Schneider
Tuesday, June 20, 2017 9:48 PM EDT
Early today, the Dow Jones made another new all-time high. Bullish, right? Technically, yes. Although the Russell 2000 provided a different experience. What are some of the different angles investors perceive?
In this article: IBB, QQQ, IWM, IYT, KRE, SMH, XRT Also: GDX, GLD, IYR, SPY, TAN, TLT, USO, UUP, XLU
Read
Biogen Ready For A Sizable Bounce
Article By: Bob Lang
Tuesday, June 20, 2017 5:45 PM EDT
The big biopharma company Biogen seems poised for an upside pop soon based on recent turnover and bullish price divergence. It has a good chance to reach the 200 ma for the first time since breaking down in late April.
In this article: BIIB
Read
Axsome Looks Good On Multiple Catalysts: Fast Track Designation Eases Liquidity Concerns
Article By: KKD Healthcare Analytics
Tuesday, June 20, 2017 11:27 AM EDT
Axsome Therapeutics Inc. (AXSM) has multiple catalysts coming up in the near future as it has two main drug candidates under Phase 3 testing for multiple conditions. The stock has shown strength as it gained over 12 percent in the past one month.
In this article: AXSM
Read
Jefferies Sees $60-$75 Per Share Buyout Range For Mallinckrodt
Article By: The Fly
Tuesday, June 20, 2017 10:44 AM EDT
Amid speculation that Mallinckrodt is seeking strategic alternatives, Jefferies analyst Anthony Petrone explored leveraged buyout scenarios in order to gauge the feasibility of a sponsor-led transaction.
In this article: MNK
Read
3 Biotech Stocks That More Than Doubled Year To Date
Article By: Arpita Dutt
Monday, June 19, 2017 2:24 PM EDT
Year-to-date (YTD), the Nasdaq Biotechnology Index is up 10.4% providing a glimmer of hope to biotech investors who saw the Index sliding 19.1% in 2016.
In this article: PBYI, SGMO, CYAD Also: PFE
Read
Dogs Of The Dow Underperformance Gap Widening
Article By: David Templeton
Sunday, June 18, 2017 7:39 PM EDT
The first six months of the year are nearly behind us so I thought it appropriate to provide an update on the performance for the 2017 Dogs of the Dow.
In this article: BA, CAT, CVX, IBM, KO, MRK, PFE, VZ, XOM, CSCO
Read
Week In Review: IHH Building $1 Billion Of China Hospitals; Seeks Deals For More
Article By: ChinaBio® Today
Saturday, June 17, 2017 4:50 PM EDT
This weeks Chinese biotech news features an IPO of Athenex, venture funding for several Chinese medical businesses and successful trials and approvals.
In this article: CSL, LLY, HCM
Read
Is This Equity Market Getting Frothy?
Article By: Robert Maltbie
Friday, June 16, 2017 6:25 PM EDT
The US equity markets have an underlying bullishness that has been absent for several years. Even in the face of rising interest rates this year, the averages keep inching higher and any market setback is temporary.
In this article: GTN, NYT, STS, IRIX, LABL, LAKE, STMP, LAND, CTRL, SNC
Read
Alnylam (ALNY) Stock To Maintain Momentum With New Patent Win
Article By: KKD Healthcare Analytics
Thursday, June 15, 2017 9:18 AM EDT
Alnylam Pharmaceuticals Inc. boosted its patent portfolio with new allowances from USPTO as the regulatory authority issued the notices with regard to the patent application.
In this article: ALNY
Read
Premarket Biotech Digest – RDHL Initiates Two Products. BMY Starts Recall, PULM Inks New Deal
Article By: KKD Healthcare Analytics
Wednesday, June 14, 2017 9:07 AM EDT
RedHill Biopharma stock perked up as the company announced starting two GI-focused products in the U.S. Aptose Biosciences stock is on rally as the company announced updates for its pipeline candidates CG'806 and APTO-253.
In this article: RDHL, APTO, BMY, ENDP, PFE, NURO, PULM, ABBV
Read
Premarket Biotech Digest – JNJ Receives EU Nod, XBIT Terminates Trial, PFE Amends Protocol
Article By: KKD Healthcare Analytics
Monday, June 12, 2017 9:17 AM EDT
Johnson & Johnson announced receiving the approval from the regulatory authorities in the EU for its planned $30 billion takeover of Actelion. Teva announced the commercial launch of the generic version of Novartis’ Pataday.
In this article: JNJ, LXRX, PFE, TEVA, XBIT, TSRO, EYEG
Read
Biotech Avoids Tech Wreck Of June 9
Article By: Rod Raynovich
Monday, June 12, 2017 1:48 AM EDT
A big part of 2017 investing strategy will be picking the right sector. Healthcare appears to offer modest returns with a dividend play.
In this article: BAC, BMY, JNJ, MRK, PFE, IBB, AAPL, AMZN, GILD, NFLX, NVDA, TSLA, SMH, XBI, XLE, XLF, XLV, FB, ABBV, GOOGL, BLUE
Read
May-Hem - Sterling Collapses
Article By: Vivian Lewis
Saturday, June 10, 2017 4:34 PM EDT
Bank of Montreal's Stephen Gallo says Brexit is "factor number one" for determining the pound's near-term direction. A minority Conservative government implies a "softer Brexit", he adds, a scenario that points to a firmer pound.
In this article: CX, ORA, SLFPY, TCTZF, INFY, BABA, INPCF
Read
Above The 40 – A Surprisingly Bullish Rotation Out Of Tech Stocks
Article By: Dr. Duru
Saturday, June 10, 2017 12:11 PM EDT
The Nasdaq took a serious shellacking just one day after confirming a bullish undercurrent for the market with another all-time high.
In this article: SPHB, SPLV, UVXY, IBB, QQQ, AAPL, AMZN, GOOG, NFLX, NVDA, IWM, MDY, XLF, XRT, FB, VIX
Read
1 to 16 of 1963 Posts
1 2 3 ... 123